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G protein-coupled receptors (GPCRs) control a variety of fundamental cellular processes by regulating phospholipid signaling pathways.
Essential for signaling by a large number of receptors is the hydrolysis of the membrane phosphoinositide PIP2 by phospholipase C (PLC) into the
secondmessengers IP3 and DAG.Many receptors also stimulate phospholipase D (PLD), leading to the generation of the versatile lipid, phosphatidic
acid. Particular PLC and PLD isoforms take differential positions in receptor signaling and are additionally regulated by small GTPases of the Ras,
Rho and ARF families. It is now recognized that the PLC substrate, PIP2, has signaling capacity by itself and can, by direct interaction, affect the
activity and subcellular localization of PLD and several other proteins. As expected, the synthesis of PIP2 by phosphoinositide 5-kinases is tightly
regulated as well. In this review, we present an overview of how these signaling pathways are governed by GPCRs, explain themolecular basis for the
spatially and temporally organized, highly dynamic quality of phospholipid signaling, and point to the functional connection of the pathways.
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GPCRs constitute a large group of membrane receptors
known to modulate a wide range of biological responses,
including cell growth, differentiation, migration, and inflam-
matory processes. Many cellular responses elicited by GPCRs
are mediated by phospholipid signaling cascades, initiated by
Gα and Gβγ subunits of heterotrimeric G proteins. The
hydrolysis of membrane phospholipids leads to the formation of
various bioactive lipid mediators, acting either as extracellular
signaling molecules or as intracellular second messengers. A
crucial second messenger-forming system is the stimulation of
phosphoinositide-specific phospholipase C (PLC) isoforms.
Upon activation, PLC enzymes hydrolyze phosphatidylinositol-
4,5-bisphosphate (PIP2) at the inner face of the plasma
membrane and thereby generate the messengers, diacylglycerol
(DAG) and inositol-1,4,5-trisphosphate (IP3). These two
signaling molecules lead to the activation of several protein
kinase C (PKC) isoforms and the release of calcium from
intracellular stores, respectively. It is now well established that
PLC stimulation plays a major role in many early and late
cellular responses to GPCR activation, including smooth
muscle contraction, secretion, neuronal signaling as well as
fertilization, cell growth and differentiation [1,2]. Phospholi-
pase D (PLD) is a distinct, phospholipid-specific phosphodies-
terase that hydrolyzes phosphatidylcholine to phosphatidic acid
(PA) and choline. PLD is rapidly activated in response to
extracellular stimuli, and the generation of PA is considered toFig. 1. Phospholipid signaling by GPCRs. GPCRs stimulate PLC isoforms that hydro
PKC isoforms and the release of Ca2+ from intracellular stores, respectively. PLC stim
contraction, secretion, and cell proliferation and differentiation. Activation of PLD le
modulates a wide array of cellular responses, including GLUT-4 translocation, ac
cascade, and mitogenesis. Stimulation of PLC and PLD enzymes by GPCRs involve m
in cellular signaling by both PLC and PLD: it serves as the major substrate for PLC
PLD enzymes, can be further phosphorylated to the lipid mediator PIP3 by PI3K, b
synthesis of PIP2 by PIP5K is regulated by Rho and ARF GTPases as well. PLC a
regulated by PKC, and PA is a strong activator of PIP5K.mediate many of the biological functions attributed to PLD and
to play important roles in the regulation of cell function and cell
fate. Indeed, activation of PLD by GPCRs has now been
established to modulate such a wide array of cellular responses
as calcium mobilization, secretion, superoxide production,
endocytosis, exocytosis, vesicle trafficking, glucose transport,
rearrangements of the actin cytoskeleton, mitogenesis and
apoptosis [3–6].
The phosphoinositide PIP2 takes a pivotal point in cellular
signaling by both PLC and PLD. PIP2 serves as the major
substrate for PLC enzymes and, at the same time, profoundly
affects the subcellular localization and activity of PLD enzymes
and many other proteins via specific interaction with unique
phosphoinositide-binding domains, including pleckstrin homol-
ogy (PH), phox homology (PX), ENTH, FERM, FYVE and
tubby domains. In this way, PIP2 (and other phosphoinositides)
modulate a remarkable number of cellular processes, such as
actin cytoskeletal dynamics, vesicle trafficking, ion channel
activity, gene expression and cell survival [7,8]. The activity
and localization of phosphoinositide 5-kinase (PIP5K) iso-
forms, which catalyze the formation of PIP2, are tightly
regulated by monomeric GTPases. The regulation of PIP5K
by GTPases likely contribute to the spatial and temporal
organization of PIP2 metabolism and, thus, direct discrete and
dynamic GPCR signaling by PLC and PLD. Consistent with
their distinct structural organization, the PLC and PLD isoforms
are susceptible to distinct modes of activation by membrane
receptors and monomeric GTPases. This review will focus onlyze PIP2 into the second messengers DAG and IP3, leading to the activation of
ulation plays a major role in many cellular responses, including smooth muscle
ads to the hydrolysis of phosphatidylcholine, and GPCR-induced PA generation
tin cytoskeleton rearrangement, activation of the Raf/MEK/ERK1/2 signaling
onomeric GTPases of the Rho, Ras, and ARF families. PIP2 takes a pivotal point
enzymes, profoundly affects the subcellular localization and enzyme activity of
ut also directly interacts with actin-remodeling proteins and ion channels. The
nd PLD signaling is even more interconnected, as PLD activity is significantly
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how signaling by these lipases is organized and connected by
small GTPases and PIP2 metabolism (Fig. 1).
2. The PLC family
At present, thirteen distinct mammalian PLC isoforms have
been identified and grouped into six families: PLC-β (1–4),
PLC-γ (1–2), PLC-δ (1,3,4), PLC-ε, PLC-ζ, and PLC-η (1–2).
The PLC isoforms share four EF-hand motifs, the X and Y
domains that form the catalytic core, and a C-terminal C2
domain [9–11]. Binding of calcium to the EF-hands of PLC-δ
may be necessary for proper interaction of the PH domain with
PIP2 [12], whereas the C2 domain may differentially support
plasma membrane localization and facilitate substrate hydro-
lysis [13]. All isoforms, with exception of PLC-ζ, have an N-
terminal PH domain that localizes the enzymes to their substrate
and other signaling components. In addition to these canonical
domains, the isoforms contain family-specific regulatory
domains to take differential positions in receptor signaling
(Fig. 2).
PLC-β enzymes are activated by heterotrimeric G protein
subunits after stimulation of GPCRs, and possess a C-terminal
regulatory domain that interacts with GTP-bound α subunits of
Gq proteins [14,15]. The C-terminus of PLC-β enzymes also
bears a GTPase-activating protein (GAP) activity mimicking
the Gαq interaction site of regulators of G protein signaling
(RGS) proteins, a family of GAP proteins for heterotrimeric G
proteins [16]. The C-terminus further triggers membrane
association and localization of PLC-β1 into the nucleus [17]
and has a binding motif, which may interact with PDZ domain-
containing proteins to promote scaffolding of signaling
molecules [18]. PLC-γ enzymes contain Src homology 2
(SH2) domains and are regulated by nonreceptor and receptor
tyrosine kinases (RTK). The second split PH domain of PLC-γ1
can interact with EF-1α, an activator of phosphoinositide
4-kinases [19], and the SH3 domain of PLC-γ1 exhibits guanineFig. 2. The PLC family. The basic structure of the PLC isoforms comprehends an N-te
domains that form the catalytic core, and a C-terminal C2 domain. In addition to thes
take differential positions in receptor signaling. The PLC-β C-terminal domain interac
contain a second split PH, two SH2 and an SH3 domain and are regulated by tyrosine
bears an N-terminal CDC25 domain with GEF activity for Ras-like GTPases as well
interactions with Ras-like GTPases. The latest isoform, PLC-η, contains a C-term
functioning.nucleotide exchange factor (GEF) activity towards PIKE, a
nuclear GTPase that activates phosphoinositide 3-kinase (PI3K)
[20]. Both mechanisms may contribute to a rapid, highly
dynamic phosphoinositide turnover in intact cells and, hence, the
localization and functionality of PLC-γ1. The SH3 domain of
PLC-γ1 also interacts with PLD2, and may therefore directly
link the two signaling phospholipase families [21]. The
archetypal PLC-δ enzymes are tightly regulated by intracellular
[Ca2+]. Activation of PLC-δ isoforms by membrane receptors is
only poorly understood, but it has been reported that the atypical
high molecular weight Gh GTPase can directly activate PLC-δ1
via interaction with the C2 domain, and can mediate PLC-δ1
activation by the oxytocin receptor, the thromboxane A2
receptor and the α1B-adrenoceptor [9–11]. PLC-ε bears an N-
terminal CDC25 domain with GEF activity for Ras-like
GTPases as well as two C-terminal Ras-binding (RA) domains,
qualifying PLC-ε for upstream and downstream interactions
with Ras-like GTPases [22–24]. PLC-ζ from sperm was found
to initiate calcium oscillations in the fertilized oocyte and trigger
embryo development [25]. The latest isoform, PLC-η, was
simultaneously described by four groups last year and likely
plays a role in neuronal functioning [26]. The distinct regulatory
domains and unique organization patterns of the mammalian
PLC isoforms apparently allow differential positioning of PLC
signaling in cellular processes.
3. Regulation of PLC-β isoforms
GPCRs can activate PLC-β isoforms by two distinct
mechanisms. Pertussis toxin (PTX)-insensitive heterotrimeric
Gq family proteins (Gq, G11, G14, G15 and G16) activate PLC-β
isoforms, but not PLC-γ, PLC-δ and PLC-ε isoforms, via GTP-
loaded Gα subunits [9–11,23]. Many GPCRs employ this
classical mode of PLC-β activation, including the receptors for
bradykinin, α1-adrenergic agonists, angiotensin II, vasopressin,
acetylcholine (muscarinic M1 and M3), thromboxane A2,
bombesin and endothelin-1. GTPγS-bound Gαq subunitsrminal PH domain (except PLC-ζ from sperm), four EF-hand motifs, the X and Y
e canonical domains, the isoforms contain family-specific regulatory domains to
ts with Gαq proteins and with PDZ domain-containing proteins. PLC-γ enzymes
kinases. The PLC-δ enzymes are tightly regulated by intracellular [Ca2+]. PLC-ε
as two C-terminal RA domains, qualifying PLC-ε for upstream and downstream
inal sequence with a PDZ-binding motif, and likely plays a role in neuronal
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β4≥PLC-β3>PLC-β2 [27]. The region required for PLC-β1
activation by Gαq is localized in the C-terminus [17]. The
crystal structure of PLC-β revealed that the C-terminus forms a
long coiled coil that dimerizes along its long axis [14], and
residues located at the outerface of the helices were identified to
specifically interact with Gαq [15]. Binding of Gαq to the C2
domains of PLC-β enzymes may additionally contribute to
enzyme activation [28].
Gβγ subunits liberated from PTX-sensitive Gi family
proteins likewise activate PLC-β (except PLC-β4) isoforms,
and also PLC-ε [9–11,29]. This mode of PLC-β activation
includes the M2 muscarinic receptors and receptors for
chemoattractants. The efficiency of PLC-β activation by Gβγ
depends on the subunit composition, Gβ1γ1/2 and Gβ5γ2
preferring PLC-β3 and PLC-β2, respectively [30]. Gβγ
subunits can bind to the PH domain of PLC-β enzymes, but
an additional site of interaction of Gβγ with PLC-β2 was
localized in the Y catalytic subdomain [31,32]. The distinct
interaction sites of Gβγ subunits may promote membrane
insertion of PLC-β enzymes. Gαq proteins were shown to
permit PLC-β stimulation by receptors acting through Gβγ
subunits of Gi proteins [33,34], suggesting that Gαq and Gβγ-
dependent signals may converge on the level of PLC-β
isozymes to gain full activation.
In addition to heterotrimeric G protein subunits, PLC-β
isozymes are also activated by Rho family GTPases. PLC-β2
is in vitro activated by Rac proteins (Rac1 and Rac2), to a
lesser extent by Cdc42, but not by RhoA [30,35]. Regulation
of PLC-β by Rho GTPases involves regions of PLC-β distinct
from those required for interaction with Gαq and Gβγ, and
stimulation of PLC-β2 by Gβγ subunits and Rac proteins was
found to occur independently [30]. Activated Rac proteins
bind to PLC-β2 and PLC-β3, but not to PLC-β1, probably
via the PH domain of the enzymes[30,36], and stimulate
PLC-β with the rank order PLC-β2>PLC-β3≥PLCβ1. Rac2
also induces membrane association of PLC-β2, which requires
the PH domain but also depends on the C-terminal region of
PLC-β2 [37]. PLC-β2 is highly expressed in myeloid cells,
and Rac proteins may be involved in stimulation of the
enzyme by chemoattractant receptors [38]. Thus, the PH
domains of PLC-β are more than tethering devices and
additionally mediate enzyme regulation by Gβγ subunits and
Rac proteins.
4. Regulation of the PLC-ε isoform
Five years ago, PLC-ε has been identified as a novel
mammalian PLC isoform with unique structural and regulatory
features. PLC-ε is most abundant in the heart, followed by the
kidney, lung and brain [22–24]. The presence of a CDC25
domain possessing Ras-GEF activity at the N-terminus and two
RA domains (RA1 and RA2) at the C-terminus directly links
PLC-ε with Ras signaling [39,40]. Indeed, PLC-ε is obviously
under control of Ras-like GTPases, in particular H-Ras, but also
Rap1A and Rap2B, as well as α subunits of G12 type proteins
and Gβγ subunits.H-Ras, and maybe Rap1A, directly binds to the RA
domains of PLC-ε [22,24], and binding of H-Ras to the RA2
domain seems critical for enzyme activation [41]. Binding of
Ras proteins to PLC-ε may not be sufficient to directly affect
its lipase activity, but profoundly changes its intracellular
localization. Stimulation of PLC-ε in intact cells seems to
involve additional cellular components, which might be
present at the plasma membranes or intracellular compart-
ments. The CDC25 domain of PLC-ε exhibits significant
GEF activity towards Rap1A, and perhaps H-Ras, but not to
R-Ras and Ral [23,42], and this domain is required for a long
lasting translocation of PLC-ε to the Golgi compartment.
PLC-ε has no GEF activity towards Rap2 proteins, structu-
rally close relatives of Rap1A, but both Rap2A and Rap2B
can bind to PLC-ε and, similar to H-Ras, Rap1A and TC21,
enhance PLC-ε activity upon cotransfection in intact cells in
an RA2-dependent manner [43–45]. Activation of PLC-ε by
Ras and Rap1A seems critical for cellular survival and
proliferation [43], and PLC-ε was shown to be involved in
Ras-mediated development of skin tumors in mice [46]. PLC-ε
can also be activated by RhoA, Rac1 and Ral. Their mode of
activation is RA2-independent, and activation by RhoA is likely
mediated by a region within the Y catalytic box of PLC-ε
[45,47].
Both Gα12 and Gα13, but not Gαq or Gαi, can increase PLC-ε
activity [23,29], and stimulation of PLC-ε by G12 proteins may
contribute to the mitogenic potential of the G12 family proteins
[48]. PLC-ε contains a domain very similar to the C-terminal
regulatory domain of PLC-β enzymes that mediates their
interaction with Gαq proteins. Also Gβγ subunits can activate
PLC-ε [29], but it is presently unclear whether the effects of
Gβγ are mediated via interaction with the PH domain of
PLC-ε. Gβ1 in combination with Gγ1, Gγ2, Gγ3 and Gγ13 all
activated PLC-ε: Gβ2 and Gβ4 equally stimulated PLC-ε,
whereas Gβ3 containing dimers were less active and Gβ5 was
inactive [29].
Consistent with its diverse regulation by G proteins, PLC-ε
was found to be stimulated by GPCRs. We have shown that
stimulation of the typically Gs-coupled β2-adrenoceptor and the
prostaglandin E1 prostanoid receptor, but also the M3
muscarinic receptor, can induce PLC-ε stimulation via Gαs,
Epac and Rap2B [49–51]. This PLC and calcium signaling
pathway is dependent on cyclic AMP, but independent of
protein kinase A (PKA). Stimulation of PLC-ε by these
receptors was specifically mediated by Rap2B, but not by H-
Ras, Rap1A and Rap2A, and involved the Rap-specific GEF,
Epac. Like PLC-ε, Epac is abundantly expressed in the heart
[52], and integration of Epac and PLC-ε in β2-adrenoceptor
signaling may modulate heart physiology. Indeed, PLC-ε−/−
mice were shown to have cardiac developmental and functional
deficits [53,54]. Alternatively, lysophosphatidic acid (LPA),
sphingosine 1-phosphate and thrombin stimulate PLC-ε via
Gα12/13 and Rap or Rho proteins, but partly also via PTX
sensitive G proteins [45,55]. Signaling to PLC-ε is clearly not
restricted to GPCRs. PLC-ε is activated by the PDGF receptor
mediated by Ras and Rap1A [43], and EGF receptor signaling
to PLC-ε is mediated by Rap2B, and involves the Rap-specific
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signaling pathways seem to converge on the level of PLC-ε.
5. PLC signaling by GPCRs
GPCRs can activate PLC-β as well as PLC-ε and, by cross-
talk with RTKs, modulate PLC-γ isoforms as well. PLC-β and
PLC-ε are diversely regulated by heterotrimeric G protein
subunits as well as monomeric GTPases, and PLC-ε is even
under control of both GPCRs and RTKs. The central position of
the individual PLC isoforms in cellular signaling demands that
their activation is tightly controlled both in space and time.
Indeed, PLC-β1 has GAP activity towards Gαq proteins, and
this mechanism, probably in concert with RGS proteins, may
ensure steady-state signal amplitude and accelerate signal
termination on agonist removal [16,57]. PLC-ε has Ras-GEF
activity and might function as an amplifier for Rap1A signaling,
leading to cellular proliferation, differentiation, lymphocyte
aggregation, T-cell anergy and platelet activation [58]. PKA and
PKC modulate PLC signaling: both inhibition and potentiation
of PLC signals have been observed probably depending on the
cellular setting. These mechanisms may, together with calcium
feedback onto PLC, contribute to oscillations in PLC-dependent
second messenger generation by GPCRs, and may thereby
control amplitude, frequency and duration of PLC signals
[59,60].
Monomeric GTPases likely direct PLC-β and PLC-ε
signaling by membrane receptors into diverse pathways at
distinct subcellular locations [61]. These pathways can be
timely dissected: the rapid and initial phase of PLC-ε activation
by PDGF was mediated by Ras, while prolonged activation of
PLC-ε was mediated by Rap1A and required the GEF domain
of PLC-ε [43]. Ras and Rap1A induced translocation of PLC-ε
to the plasma membrane and to perinuclear Golgi regions,
respectively [24], and likewise, Ras and Rap1A differentially
mediated activation of the extracellular signal-regulated kinase
(ERK) pathway by PLC-ε via Raf-1 kinase and B-Raf kinase
[23,24].
Multiple PLC isoforms can be activated by a single receptor
and may act in succession or in adjacent signaling cascades. For
instance, PLC-δ1 likely functions as a calcium signal amplifier
and is activated by capacitative calcium entry upon PLC-β
activation [62], a process shown to involve PLC-γ [63], but
PLC-β can also directly bind and regulate PLC-δ1 [64]. GPCRs
for endothelin, LPA and thrombin were shown to independently
activate both PLC-β and PLC-ε, but with agonist- and isoform-
specific profiles [65]. Thus, PLC-β was predominantly
involved in acute, and PLC-ε in sustained PI hydrolysis. We
found that the M3 muscarinic receptor, which activates PLC-β
by coupling to Gαq, can additionally activate PLC-ε by two
different mechanisms. Activation of PLC-ε by Rap2B could be
achieved by the cyclic AMP-dependent GEF, Epac [49,50], but
alternatively, by the calcium and DAG-sensitive exchange
factors RasGRP1 or RasGRP3 (own unpublished data). Like-
wise, stimulation of PLC-ε by the EGF receptor depended on
Rap2B stimulation by RasGRP3, which required tyrosine
phosphorylation by Src as well as active PLC-γ and calcium[56]. This exciting cascade positions PLC-ε downstream of
PLC-γ (and maybe PLC-β) during single receptor action,
suggesting specific and coordinated functions for these PLC
isoforms.
Recruitment of PLC isozymes to specialized membrane
compartments likely contributes to the spatial regulation of
PLC signaling. The PH domain of PLC-δ1 binds to both PIP2
and IP3 which may successively control the membrane
localization and catalytic activity of PLC-δ1, and the
termination of this process by the formation of IP3. The PH
domain of PLC-β1 preferentially binds phosphatidylinositol-
3-phosphate and membrane recruitment of PLC-β1 is
supported by PI3K activity [66], but also Gβγ subunits and
Rac can tether PLC-β isoforms via their PH domains. In
addition, PDZ domain-containing proteins induce clustering
of PLC-β enzymes and scaffolding of signaling molecules
and apparently enhance PLC-β activation by GPCRs [18].
6. PLD isoforms and phosphatidic acid
Two mammalian PLD genes, PLD1 and PLD2, both with
two splice variants have been identified [67–70]. PLD1 and
PLD2 share four highly conserved catalytic domains compris-
ing two HKD motifs, which are essential for catalytic activity
(Fig. 3). PLD1 and PLD2 further possess N-terminal PH and PX
domains as well as a polybasic PIP2 binding motif within the
catalytic core, and PIP2 profoundly affects the cellular
localization and enzyme activity of both isoforms [71–73].
PLD1 is extensively regulated by PKC and by GTPases of the
ARF and Rho families [5,74], but PLD2 responds to ARF and to
PKC as well [75]. In line with a role for PLD enzymes in
different cellular tasks, PLD1 and PLD2 show a diverse
subcellular distribution. PLD1 is found throughout the cell, but
primarily localizes to intracellular compartments, including the
Golgi apparatus, endosomes, and the perinuclear region [76–
78]. PLD2 is almost exclusively present at the plasma
membrane in lipid raft fractions [79]. Also PLD1 is found in
lipid rafts, and both PLD enzymes have been shown to associate
with membrane receptors.
PLD can modulate cellular signaling due to the formation of
several bioactive lipids, but most cellular responses are likely
mediated by the immediate PLD reaction product PA [6]. PA can
be further metabolized to the GPCR agonist LPA by phospho-
lipase A2 and to DAG by phosphatidate phosphohydrolase.
However, GPCR-induced DAG production seems to mainly
result from PIP2 breakdown by PLC [80]. PA directly binds to
cellular proteins, such as Raf-1 kinase, protein phosphatase 1,
and mTOR, and can affect both cellular localization and activity
of these proteins. Quenching of PA synthesis by primary
alcohols has proven useful to investigate the involvement of
PLD enzymes in cell physiology, and demonstrated a role for
PLD in a variety of signaling processes, such as activation of
phosphoinositide (PI3K, PIP5K) and protein (Akt, ERK1/2)
kinases, calcium mobilization, agonist-induced secretion and
actin stress fibre formation, and ERK-driven mitogenesis.
Whether the effects are directly mediated by PA, or via
generation of LPA is not always definitively answered. Inactive
Fig. 3. Domain structure of PLD and PIP5K isoforms. The PLD isoforms PLD1 and PLD2, both with at least two alternate splice variants, contain N-terminal PX and
PH domains and the highly conserved domains I–IV. The domains II and IV contain HKD sequence motifs that are necessary for catalytic activity. N-terminal to
domain III is a well conserved basic sequence that binds PIP2, whereas Gβγ subunits, PIP3 and other phosphoinositides interact with the PX/PH region. PLD1 is
distinguished by a loop region that seem to contribute to the regulation of PLD1 activity. The three PIP5K isoforms contain a conserved catalytic core with an
activation loop (AL), that determines substrate specificity as well as subcellular targeting of the enzymes. Full-length PIP5K-Iγ, but not two shorter PIP5K-Iγ splice
variants, comprises a C-terminal sequence that binds to the FERM domain of talin.
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discriminate isoform-specific PLD functions and showed that
PLD1 is implicated in agonist-induced secretion, actin organiza-
tion, and cell adhesion and migration [81–84], and PLD2 in
endocytosis and recycling of membrane receptors [85–87].
7. Regulation of PLD isoforms by GPCRs
Signal-dependent activation of PLD enzymes has been
demonstrated in numerous cell types, and both PLD1 [88,89]
and PLD2 [90,91] seem to respond to GPCRs. As nearly every
membrane receptor known to stimulate PLC isoforms caused
PLD stimulation, it was assumed that PLD activation might be
secondary to PLC-initiated increase in cytosolic [Ca2+] and
activation of PKC isoforms. Indeed, PKC inhibitors and down-
regulation of DAG-dependent PKC reduced receptor-induced
PLD responses. A physical association between PLD with PKC
isoforms has been reported, resulting in strong activation of in
vitro PLD1 activity, and the major interaction site was identified
within the N-terminus of PLD1 [92]. Moreover, PLD1 mutants
unresponsive to PKC did poorly respond to activation of
GPCRs [88] or to active Gαq [93]. However, stimulation of
PLD in some receptor systems, including M3 muscarinic and
α1-adrenergic receptors, were actually PKC-independent [94–
97], suggesting that PLD stimulation must not necessarily be
secondary to PLC stimulation.
Stimulation of PLD by GPCRs was shown to involve both
PTX-insensitive [94,98] and PTX-sensitive [99,100] G pro-
teins. Besides Gq, G12 family proteins can stimulate PLD as well
[101], and RGS proteins, that act as α subunit-specific GAPs,
have been used to demonstrate that G12 proteins mediate PLD
activation by the M3 muscarinic [102], the PAR1 [103], and the
Ca2+-sensing receptor [104] as well as mechanical force [105].
As forskolin and cAMP were shown to activate PLD mediated
by PKA and ERK1/2 [106,107] or, alternatively, by Epac and R-
Ras [108], Gs proteins are also expected to couple to PLD. PLD
activation is also controlled by βγ-subunits [109,110] and Gβγ
can directly interact with PLD [111].8. Regulation of PLD by monomeric GTPases
ARF proteins are involved in the regulation of intracellular
transport and membrane trafficking, and have been identified as
regulators of PLD activity. Although the interaction site on PLD
for ARF has not yet been precisely defined, it is well established
that ARF proteins, particularly ARF1 and ARF6, directly
activate PLD1 and can also activate, to a lesser extent, PLD2
[67,68]. Initial evidence for participation of ARF proteins in
receptor-mediated PLD stimulation was based on in vitro
reconstitution studies with membranes and ARF-depleted
permeabilized cells. In intact cells, receptor signaling to PLD
was reduced with the ARF-GEF inhibitor Brefeldin A [99,112–
114]. Likewise, sequestration of ARF-GEFs by the ARF-related
protein ARP inhibited M3 muscarinic receptor signaling to PLD
[115]. Rho proteins, particularly RhoA, Rac1 and Cdc42, which
control actin cytoskeleton reorganization, exclusively activate
PLD1 by direct interaction with its C-terminus, and this
activation can be triggered by PKC-α and ARF1 [5,74].
Clostridial toxins that specifically inactivate Rho proteins, and
expression of inactive Rho mutants have been used to study the
role of Rho proteins in signaling to PLD. Thus, RhoAwas found
to be relevant for PLD stimulation by both GPCR (bradykinin,
sphingosine-1-phosphate and LPA) and RTK (PDGF) agonists.
We found that Rho proteins, particularly RhoA, specifically
affect signaling to PLD by the muscarinic M3 receptor, without
changing PLD stimulation by RTKs in HEK-293 cells [116–
119]. Likewise, regulation of mTOR by LPA, but not PDGF,
involved PLD1 activation by Rho GTPases [120]. PLD
stimulation by RhoA may be mediated by direct interaction,
but apparently also involve Rho-dependent serine/threonine
kinases. Thus, Rho-kinase was found to mediate PLD
activation by the M3 muscarinic receptor [119] and PKN to
directly interact with PLD [121] and mediate PLD activation by
the α1-adrenergic receptor [122].
The contribution of ARF and Rho proteins to GPCR-induced
PLD stimulation likely depends on receptor function in specific
cellular settings. For instance in HEK-293 cells, the PLD
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concerted action by independent ARF and Rho pathways, and
both ARF1 and RhoA translocated to the membrane compart-
ment after receptor activation [112,123]. In cardiomyocytes,
Rho proteins affect signaling to PLD by both endothelin-1 and
thrombin, apparently by controlling PIP2 synthesis, whereas
ARF selectively affects signaling by the PAR1 receptor [103].
The picture emerges that G12 proteins induce PLD activation by
Arf and Rho proteins, whereas Gq proteins control PLD in a
PKC-dependent manner. ARF and Rho have been found to
localize in PLD containing lipid rafts, and ARF proteins to
directly interact with GPCRs [124]. The identification of ARAP
proteins, which activate ARF and Rho signaling pathways and
can be activated by Ras-like GTPases, suggest even more
dynamic signaling towards PLD [125].
PLD1 can also directly interact with RalA, and a Ras/Ral
signaling cascade was shown to regulate PLD responses. Ral
apparently cooperates with ARF [126,127] and Rho proteins
[128,129] to achieve full PLD activation. Experiments with
clostridial toxins and inactive mutants located Ras and RalA in
RTK, but not muscarinic M3 receptor signaling to PLD, and this
Ras/Ral-dependent signaling cascade was dependent on PKC-α
and a Ral-specific GEF [117,118]. Likewise, Ras proteins were
found to modulate PLD responses by PDGF [130], and RalA to
affect EGF receptor signaling to PLD [131]. Ras-related R-Ras
was recently found to be involved in GPCR signaling to PLD
[108], but a contribution of Ral to GPCR-induced PLD
activation seems unlikely [132].
9. Regulation of PIP2 synthesis by GPCRs and GTPases
Although PIP2 represents less than 1% of cellular phospho-
lipid, this polyphosphoinositide directly affects an astonishing
variety of fundamental cellular processes, including the
regulation of the actin cytoskeleton, membrane trafficking and
ion channel activity [7,8]. To execute these different tasks, PIP2
is generally supposed not to be randomly distributed in cells, but
to be organized in confined regions, for instance lipid rafts, that
may control specific cellular functions [133,134]. The synthesis
and turnover of the lipid in particular subcellular compartments
is believed to be detailed and distinctly regulated, especially by
monomeric GTPases [135]. PIP2 is mainly generated via the
phosphorylation of phosphatidylinositol-4-phosphate by
PIP5K. Three isoforms of PIP5K (designated Iα, Iβ and Iγ)
with alternative splice variants have been cloned and character-
ized (Fig. 3) [136–138]. The existence of PIP5K isoforms likely
contributes to the organization of diverse structural and
functional PIP2 pools. For instance, the short PIP5K-Iγ splice
variant seems the major producer of the PIP2 pool that supports
GPCR-induced IP3 generation [139]. PIP2 is not only consumed
by PLC-mediated hydrolysis, but can also be further phos-
phorylated by PI3K to PIP3, which recruits and activates
mediators involved in actin remodeling, mitogenesis and
survival [140]. Dephosphorylation of PIP2 by inositol polypho-
sphate 5-phosphatases, such as synaptojanin, is clearly involved
in the regulation of local PIP2 concentrations and is indis-
pensable for PIP2 recycling during vesicle trafficking [141].The synthesis of PIP2 can be stimulated by both GPCRs and
RTKs [8]. Modulation of PIP2 synthesis by GPCRs has been
mainly studied in platelets, where stimulation with thrombin
resulted in enhanced PIP2 formation [142] and in increased
association of PIP5K with the cytoskeleton [143]. The receptor-
induced stimulation of PIP5K may be directly involved in actin
cytoskeletal regulation and/or to guarantee efficient signaling,
for instance by PLC. We found that pulse stimulation of various
GPCRs induced a strong and long-lasting potentiation of
agonist-induced PLC activation [144,145]. This PLC sensitiza-
tion was apparently dependent on Gi proteins and PKC, and
could be partly explained by an increase in the cellular level of
PIP2. In agreement, GPCR-induced stimulation of PIP2
synthesis was found to be blocked by PTX [146], and
stimulation of PKC isoforms by phorbol esters greatly enhances
PIP2 synthesis [147–149]. Indeed, LPA-induced PKC activa-
tion increased PIP5K activity, most probably by stimulating
PIP5K dephosphorylation by protein phosphatase 1 [150].
PIP5K is, like PLD, under control of both Rho and ARF
family GTPases. RhoA stimulates PIP2 synthesis [151], and
PIP5K functions downstream of RhoA in actin organization
[152]. We have shown that Rho-kinase is involved in RhoA-
dependent regulation of PIP5K activity [153], and PIP5K was
found to play an essential role as downstream effector of RhoA
and Rho-kinase in neurite remodeling [154,155] and to mediate
the effects of RhoA on ERM (ezrin, radixin, moesin) activation
and microvilli formation [156,157]. PIP5K isoforms are also
activated by Rac proteins and seem critical mediators of Rac-
dependent actin remodeling. PIP5K mediates actin filament
assembly induced by thrombin or Rac1 [158] and membrane
ruffle formation by PDGF [159], and PIP2 functions down-
stream of Rac proteins in pollen tube elongation [160]. PIP5K
isoforms were found to physically associate with both RhoA
[161] and Rac1 [158]. Cdc42 does not interact with PIP5K
[162,163], but markedly stimulates PIP2 synthesis [163], and it
is speculated that the interaction with the Rho GTPases serves
the recruitment of PIP5K to specific cellular compartments.
PIP5K is also activated by ARF proteins. ARF1 mediates
PIP5K activation [164] and recruitment to the Golgi complex
[165]. ARF6 colocalizes with PIP5K and PIP2 on the plasma
membrane and endosomal structures [166,167], and the ARF6-
regulated PIP5K activity and organized PIP2 turnover is
apparently critical for regulated secretion [167–170], but also
affects phagocytosis [171] as well as neurite formation [172].
10. Interaction of phosphoinositide metabolism with PLC
and PLD
PIP2 takes a strategic position in phospholipid signaling by
GPCRs. PIP2 is the major PLC substrate, and both PLD
enzymes have an almost absolute requirement for the lipid. Vice
versa, all PIP5K enzymes are specifically and potently
stimulated by PA [138,173,174]. This stimulation may be
essential for resynthesis of PIP2 in response to PIP2 hydrolysis
by PLC and subsequent conversion of DAG to PA. Alter-
natively, PA is generated by PLD, and DGK- as well as PLD-
derived PA was able to stimulate PIP5K activity in vivo [175].
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regulation of these enzymes by ARF and Rho GTPases point
to concerted mechanisms in cellular actions, involving acute,
localized PIP2 and PA synthesis. Indeed, phosphoinositide
kinases and PLD might directly cooperate in the control of
cellular processes. Both PLD1 and PLD2 interact with PIP5K-
Iα, and PLD2 recruits PIP5K-Iα to a submembraneous
vesicular compartment [176]. Quenching of PA production
with primary alcohols inhibited PIP2 synthesis and led to
disruption of Golgi membranes [177], blockade of clathrin-coat
assembly [178] and inhibition of ARF1-reconstituted secretion
[179], demonstrating that PLD-induced PIP2 synthesis is
essential for maintaining the function of the Golgi apparatus
and the endo- and exocytotic machinery. An ARF1 mutant that
selectively activates PIP5K, but not PLD activity, demonstrated
that both PLD-derived PA and direct activation of PIP5K by
ARF1 contribute to the regulation of PIP2 synthesis in intact
cells [180].
We have to realize that receptor-induced hydrolysis of PIP2
by PLC leads, in addition to second messenger generation, to
the consumption of PIP2 [181], which likely affects cellular
processes. Agonist-induced PLC signaling (for instance by the
muscarinic M1 receptor or the α1-adrenoceptor) or expression of
active Gαq resulted, most probably by causing PIP2 depletion,
in the inactivation of various ion channels [182–185], the
release of gelsolin and actin remodeling [186,187], and
apoptosis due to suppression of the PI3K protective pathway
and attenuation of Akt phosphorylation [188]. Reversely,
sequestering of PIP2 by profilin and tubulin at high concentra-
tions was shown to inhibit PLC signaling [189,190]. Reduction
of cellular PIP2 by the actin binding protein fodrin [191] or the
PIP2 phosphatase synaptojanin [192] likewise inhibited PLD
activity. Inactivation of Rho GTPases also reduced cellular PIP2
levels, resulting in inhibition of receptor-mediated inositol
phosphate formation by PLC [193] as well as diminished PLD
stimulation [194]. The inhibition of PLD responses after Rho
inactivation could be largely rescued by the addition of PIP2,
indicating that Rho proteins actually affect PLD via PIP5K
regulation [116,194]. These findings suggest that PLD enzymes
may be implicated in various phosphoinositide-driven cellular
transport processes.
In addition, PA can also modulate the activity of PLC
enzymes. PLC-γ1 binds specifically via its SH3 domain to the
PX domain of PLD2 [21], and PIP2-dependent membrane
recruitment and activation of PLD2 may result in co-transport of
PLC-γ1 and PA-induced activation of PLC-γ1. PA also
enhances PLC-β1 activity, and renders PLC-β1 less sensitive
to inhibition by PKC [195].
11. Concluding remarks
Our view of how GPCRs transduce signals into cells has
fundamentally changed during the last decade. It is now
appreciated that a particular receptor does not merely activate
a single second messenger system in a fixed, preassigned
manner. Dependent on the cellular context, GPCRs rather
communicate with other GPCRs and RTKs as well, couple todifferent heterotrimeric G protein families and can drive diverse
signaling networks which are additionally directed by small
GTPases. We presented an overview of the remarkable progress
in our knowledge about the mechanisms of signal integration
fromGPCRs to the distinct PLC and PLD enzymes. Signaling by
these enzymes contribute to very different processes to allow
specific cellular tasking. Protein–protein and protein–lipid
interactions mediated by distinct regulatory domains confer
specificity into the highly dynamic organization of phospholipid
signaling in space and time, and tightly controls transient or
sustained phospholipase signaling. The appropriate intracellular
localization of the signaling units is controlled by small
GTPases, calcium, cAMP and phosphoinositides, and the
turnover of PIP2 and other polyphosphoinositides affect the
quality of PLC and PLD signaling. Agonist-induced recruitment
and compartmentalization of signaling components, for
instance in lipid rafts and other microdomains, likely allows
localized changes in effectors and initiation of cellular pro-
cesses without global changes to avoid unwanted side-effects.
On the other hand, it is becoming increasingly clear that the
products generated (as well as consumed) by PLC, PLD, and
phosphoinositide kinases and phosphatases act in close
harmony to effectively accomplish cellular signaling. In the
coming years, we expect a great expansion in our under-
standing of how membrane receptors control the temporal and
spatial production of second messengers to regulate a diversity
of cellular processes.
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